Health Canada issues recall for cannabis products containing undeclared intoxicating cannabinoid

| David Brown

An Alberta-based cannabis company has recalled several cannabis oils and softgels due to the “presumed presence” of hexahydrocannabinol (HHC), considered by Health Canada to be an intoxicating cannabinoid.

HHC is a “semisynthetic CBD” often synthesized from CBD.

The recall involves six lots of products from cannabis producer iNaturally Organic Inc’s Emprise CBN+CBD 50mg Softgels, NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil Softgels, and NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil cannabis extracts.

The NuLeaf Naturals oil contains Delta 9, CBC, CBD, CBG, and CBN each at 3 mg per softgel. The NuLeaf Naturals softgels contain CBC, CBD, CBG and CBN, each at 15 mg/ml.

The recalled products were sold in Ontario, British Columbia, Alberta, Manitoba, Saskatchewan, and the Yukon, and through medical cannabis platforms Herbal Dispatch, Open Fields Winnipeg, and Médicibis.

Health Canada says the recall is due to the identified hazard of the presumed presence of hexahydrocannabinol, which consumers may not be aware of. To date, iNaturally Organic Inc. says it has received two adverse reaction reports about these products. Health Canada has received three adverse reaction reports and one complaint related to these products.

There were 8,526 units of Emprise CBN+CBD 50mg Softgels distributed, 2,286 units of NuLeaf Naturals 1,800 mg Full Spectrum Hemp Multicannabinoid Oil Softgels (with Delta 9, CBC, CBD, CBG and  CBN each at 3 mg per softgel) distributed, and 2,534 units of NuLeaf Naturals 1,800 mg Full Spectrum Hemp Multicannabinoid Oil (CBC, CBD, CBG and CBN, each at 15 mg/ml) distributed from December 2022 to May 31, 2024.

Health Canada says consumers should immediately stop using the product, either returning the product to where it was purchased or disposing of it. 

Mukhdeep Mangat, VP of operations at Emprise, tells StratCann that they have independent lab tests showing no presence of HHC and were surprised by Health Canada’s findings.

“Analytical testing laboratories working with iNaturally Organic did not detect HHC in any of the products prior to batch release.”   

“iNaturally Organic received two adverse event reports about all three products combined.  Health Canada received three adverse event reports and one complaint.  The adverse event reports and complaint total six reports after sale of well over 10,000 units total of the three products, or less than one in 1,000 units.  

“iNaturally Organic prioritizes the health of its customers and is investigating Health Canada’s assertion of presumed presence of HHC, despite no evidence of HHC in the products from analytical testing laboratories working with iNaturally Organic.”